Summit Financial Group, Inc. Amgen Inc Transaction History
Summit Financial Group, Inc.
- $279 Million
- Q1 2024
A detailed history of Summit Financial Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Summit Financial Group, Inc. holds 1,287 shares of AMGN stock, worth $408,596. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,287
Previous 1,323
2.72%
Holding current value
$408,596
Previous $381,000
4.2%
% of portfolio
0.13%
Previous 0.15%
Shares
10 transactions
Others Institutions Holding AMGN
# of Institutions
3,056Shares Held
409MCall Options Held
7.19MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.5 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.2 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.59 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.56 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $170B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...